We have performed microsecond molecular dynamics (MD) Instead, protein pK a calculations indicate that SLN stabilizes a metal ion-free SERCA state (E1$H þ 771 ) protonated at residue E771, but ionized at E309 and D800. We conclude that both SLN and PLB inhibit SERCA by populating a similar metal ion-free intermediate state. We propose that (i) this partiallyprotonated intermediate serves as the consensus mechanism for SERCA inhibition by other members of the SERCA regulatory subunit family including myoregulin and sarcolamban, and (ii) this consensus mechanism is utilized to regulate Ca 2þ transport in skeletal and cardiac muscle, with important implications for therapeutic approaches to muscle dystrophy and heart failure.
a b s t r a c t
We have performed microsecond molecular dynamics (MD) simulations and protein pK a calculations of the muscle calcium pump (sarcoplasmic reticulum Ca 2þ -ATPase, SERCA) in complex with sarcolipin (SLN) to determine the mechanism by which SLN inhibits SERCA. SLN and its close analog phospholamban (PLN) are membrane proteins that regulate SERCA by inhibiting Ca 2þ transport in skeletal and cardiac muscle. Although SLN and PLB binding to SERCA have different functional outcomes on the coupling efficiency of SERCA, both proteins decrease the apparent Ca 2þ affinity of the pump, suggesting that SLN and PLB inhibit SERCA by using a similar mechanism. Recently, MD simulations showed that PLB inhibits SERCA by populating a metal ion-free, partially-protonated E1 state of the pump, E1$H with calculation of domain dynamics in the cytosolic headpiece and side-chain ionization and occupancy in the transport sites. We found that SLN increases the distance between residues E771 and D800, thereby rendering E1$Mg 2þ incapable of producing a competent Ca 2þ transport site I. Following removal of Mg 2þ, a 2-ms MD simulation of Mg 2þ -free SERCA-SLN showed that Mg 2þ does not re-bind to the transport sites, indicating that SERCA-SLN does not populate E1$Mg 2þ at physiological conditions.
Instead, protein pK a calculations indicate that SLN stabilizes a metal ion-free SERCA state (E1$H
Introduction
The muscle calcium pump (sarcoplasmic reticulum Ca 2þ -ATPase, SERCA) is an integral membrane protein responsible for the transport of Ca 2þ from the cytosol into the sarcoplasmic reticulum (SR) lumen of cardiac and skeletal muscle cells [1] . SERCA uses the energy derived from hydrolysis of one ATP molecule and the counter-transported exchange of two protons [2, 3] . Two membrane proteins are known to regulate SERCA activity: the 52-residue phospholamban (PLB) and the 31-residue sarcolipin (SLN). PLB is expressed in cardiac muscle and to a lesser extent in slow-twitch skeletal muscles, whereas SLN is predominantly expressed in skeletal muscles, but it is also expressed in atria [4, 5] . Transient expression of SLN has also been found in the left ventricle in human Takotsubo cardiomyopathy [6] . SLN and PLB binding to SERCA have different functional outcomes. PLB controls Ca 2þ affinity in a phosphorylation-dependent manner but has little or no effect on maximal velocity (V max ) [7] , thus effectively regulating cardiac function during rest and exercise [8] . SLN also controls Ca 2þ affinity of SERCA yet increases slippage of Ca 2þ into the cytosol instead of the SR lumen [9] , thus contributing to non-shivering thermogenesis in skeletal muscle [10] . We provide the first report that identifies a consensus mechanism for SERCA inhibition by SLN and PLB in atomic-level detail, with important implications for structurebased therapeutic approaches to heart failure and muscle dystrophy.
Materials and methods

Protein pK a calculations
We used PROPKA 3.1 [18, 19] to calculate the pK a values of acidic residues in the transport sites of SERCA. PROPKA estimates empirical pK a values of ionizable groups in proteins and proteinligand complexes based on the 3D structure, and benefits from explicitly incorporating the Coulombic interactions that arise from mutually titrating residues via the Tanford-Roxby procedure [20] .
Setting up SERCA-SLN for simulation
We used the crystal structure of E1$Mg 2þ -SLN (PDB code: 3w5a [14] ) as a starting structure for our simulations. We adjusted the charges on ionizable residues to correspond to their calculated values at pH~7.0, as follows. For E1$Mg 2þ -SLN, residues E309, E771
and D800 were calculated to be ionized, and E908 was protonated.
For Mg 2þ -free SERCA-SLN, pK a calculations predict residues E309 and D800 were ionized, and E771 and E908 were protonated. The complexes were inserted in a 12 Â 12 nm bilayer of POPC and solvated using TIP3P water molecules. K , we used a set of new CHARMM parameters [23] .
Molecular dynamics simulations
MD simulations of SERCA-SLN were performed with NAMD 2.9 [24] , periodic boundary conditions [25] , particle mesh Ewald [26, 27] , a non-bonded cutoff of 0.9 nm, and a 2 fs time step. The NPT ensemble was maintained with a Langevin thermostat (310 K) and an anisotropic Langevin piston barostat (1 atm). We performed two simulations: a 0.5-ms trajectory of E1$Mg 2þ -SLN and a 2-ms trajectory of Mg 2þ -unbound SERCA-SLN.
Results
Structural dynamics of E1·Mg 2þ -SLN
We performed a 0.5-ms MD simulation of E1$Mg 2þ -SLN to determine the structural dynamics of the crystallographic complex ( Fig. 1A ) in solution. We measured the backbone root-mean-square deviations (RMSD) for each functional domain of SERCA to determine the changes in SERCA (Fig. 1B) . We found that the 10-helix transmembrane (TM) domain of SERCA rapidly settles to a plateau at 0.13 nm, indicating that its structure is nearly identical to that in the crystal structure of E1$Mg 2þ -SLN. Each domain in the cytosolic headpiece of E1$Mg 2þ -SLN undergoes relatively largeamplitude structural dynamics (RMSD ¼ 0.3e0.8 nm) in this time scale (Fig. 1B) . The dynamic nature of the cytosolic headpiece, and in particular of the A domain, is in line with previous studies showing that the headpiece is inherently flexible in the E1 state in the absence and presence of PLB [16, 17] . We also evaluated the structure and mobility of SLN in the complex. We found that residues R3-Q30 of SLN exclusively populate an a-helical structure in the trajectory. Root-mean square fluctuations (RMSF) of the main chain Ca atoms of SLN showed that, except for residues M1, E2, and Y31, SLN has very low mobility in the complex (RMSF < 0.15 nm, Fig. 1C ).
Structure of transport site I in E1·Mg 2þ -SLN
We measured intramolecular distances D800-E771 and E771-E908, and intermolecular distance N11 SLN -G801 SERCA to determine 2B ). The formation of this hydrogen bond occurs simultaneously with a 0.3-nm increase in the distance between E771 and D800, indicating that SLN pulls D800 away from site I even in the presence of bound Mg 2þ ( Fig. 2A and B) . The distances D800-E771
and D800-E908 are~0.3 nm longer than those expected for competent transport site geometries [16] These results indicate that SLN disfavors the formation of a competent transport site I of SERCA.
Protein pK a calculations of SERCA-SLN ± Mg 2þ
We recently found that the distorted transport site geometry shown in Fig. 2B promotes protonation of residue E771 for PLBbound SERCA [17] . Therefore, we used PROPKA to perform empirical pK a calculations of acidic residues in the transport sites of E1$Mg 2þ -SLN in the presence and absence of bound Mg 2þ . The acidic residues analyzed here are E309, E771, D800, and E908. . This simulation was performed to evaluate the structural properties of the protonated complex, and to determine whether E1$Mg 2þ -SLN is populated at physiologically relevant Mg 2þ concentrations.
Structural dynamics of E1·H
þ
-SLN
We performed a 2-ms MD simulation of the SERCA-SLN complex starting from the structure of E1$Mg 2þ -SLN at t ¼ 0.5 ms, but in the absence of bound Mg 2þ . Time evolution of RMSD values for each functional domain of SERCA showed that the TM domain undergoes minor structural changes (RMSD < 0.2 nm), but it is structurally stable in the trajectory (Supplementary Fig. S1 ). As in E1$Mg 2þ -SLN, the cytosolic domain is mobile; however, all three N, A and P domains become less mobile after t ¼ 1.3 ms (Supplementary Fig. S1 ).
Calculation of RMSF values for SLN showed that, except for residues M1, E2 and Y31, SLN has very low mobility in the complex (RMSF < 0. 15 
Structural comparison of transport site I in E1·H þ
-SLN and E1·H þ
-PLB
We measured the distances D800-E771 and E771-E908 to evaluate the structural arrangement of transport site I in E1$H þ 771 -SLN (Fig. 3A) . Analysis of the time-dependent distance plots show that interresidue distances in transport site I do not fluctuate substantially in the trajectory. Comparison between the interresidue distances in E1$H þ 771 -SLN with distance distributions calculated from three independent MD trajectories of E1$H þ 771 -PLB (Fig. 3B) indicate that both SLN and PLB produce identical structural arrangements of transport site I of the E1 state (Fig. 3C) .
We recently showed that the transport sites of PLB-bound SERCA bind K þ ions transiently and non-specifically [17] . Therefore, we investigated the K þ interactions with the transport sites of E1$H ( Fig. 4A) . The binding preference for each site is different for SLNand PLB-bound SERCA (Fig. 4B) . Despite this variability, we found that K þ sites 1 and 2 are occupied for~40% of the time in both SLNand PLB-bound E1$H þ 771 . These sites are located near residue D800, which is ionized in E1$H Table 1 Predicted pK a values of acidic residues in the transport sites. 
Discussion
Protein pK a calculations and MD simulations showed that SLN induces structural changes in the transport sites that correspond to those previously identified as inhibitory. This local structural change occurs in the presence and absence of bound Mg 2þ , indicating that the effect of SLN on SERCA is independent of the type of metal ion bound in the transport sites.
Protein [17] . These findings are in line with experimental data showing that both SLN and PLB decrease the apparent Ca 2þ affinity of SERCA [11, 12] . It is possible that other newly-discovered SERCA regulators sarcolamban (SCL) [29] and myoregulin (MLN) [30] Further studies will be needed to answer questions regarding the functional differences among these regulatory proteins. For example, if PLB and SLN induce the same structural changes in the transport sites (Fig. 3) and populate the same inhibitory intermediate, why is only SLN able to uncouple SERCA [36] ? What are the mechanisms by which the luminal tail in SLN regulates SERCA [11] ? What about other post-translational protein modifications such as SLN acylation [37] ? What is the role of SLN self-oligomerization in SERCA regulation [38] ? Complementary experiments and simulation studies on SERCA regulation will be needed to test these questions directly.
Conclusion
We important implications for therapeutic approaches to muscular dystrophy and heart failure. -PLB represent the average from three independent 1-ms simulations reported in Ref. [17] . (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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